Public, NASDAQ:NCST
NASDAQ Global Market
Westaim announces 2008 first quarter results
Date: Mon, 12 May 2008 22:18:03 GMT
Tags:
Westaim announces 2008 first quarter results
Canada NewsWire (press release) - May 12, 2008
Canada NewsWire (press release) - May 12, 2008
CALGARY , May 12 / CNW / - The Westaim Corporation announced today that for the first quarter ended March 31 , 2008 , it recorded a net loss of $6.9 million or 7 cents per share , on revenues ...
NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
Date: Thu, 08 May 2008 01:13:49 GMT
Tags:
NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
dBusinessNews Boston (press release) - May 8, 2008
dBusinessNews Boston (press release) - May 8, 2008
WAKEFIELD - - NUCRYST Pharmaceuticals , a developer and manufacturer of medical products that fight infection and inflammation , today announced the appointment of David B . Holtz as Vice President ...
NUCRYST Names David Holtz Vice President And Chief Financial Officer - Update
Date: Wed, 07 May 2008 23:50:38 GMT
Tags:
NUCRYST Names David Holtz Vice President And Chief Financial Officer - Update
RTT News - May 7, 2008
RTT News - May 7, 2008
( RTTNews ) - Wednesday , NUCRYST Pharmaceuticals Corp . ( NCST : News , Chart , Quote ) , a manufacturer of medical products , announced that it has appointed David Holtz as its new Vice President ...
NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
Date: Wed, 07 May 2008 21:15:40 GMT
Tags:
NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
TMCnet - May 7, 2008
TMCnet - May 7, 2008
WAKEFIELD , MA , May 7 / CNW / - NUCRYST Pharmaceuticals , a developer and manufacturer of medical products that fight infection and inflammation , today announced the appointment of David B ...
NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
Date: Wed, 07 May 2008 21:12:02 GMT
Tags:
NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
PR Newswire (press release) - May 7, 2008
PR Newswire (press release) - May 7, 2008
WAKEFIELD , MA , May 7 / PRNewswire - FirstCall / - NUCRYST Pharmaceuticals , a developer and manufacturer of medical products that fight infection and inflammation , today announced the appointment ...
NUCRYST Announces First Quarter 2008 Financial Results - PR Newswire (press release)NUCRYST PHARMACEUTICALS CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and (EDGAR Online)
Date: Tue, 27 May 2008 14:39:39 Etc/GMT
Tags:
NUCRYST PHARMACEUTICALS CORP. Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
Date: Wed, 14 May 2008 21:00:43 Etc/GMT
Tags:
NUCRYST PHARMACEUTICALS CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and (EDGAR Online)
Date: Tue, 13 May 2008 21:09:58 Etc/GMT
Tags:
NUCRYST PHARMACEUTICALS CORP. Financials (EDGAR Online Financials)
Date: Fri, 9 May 2008 13:05:16 Etc/GMT
Tags:
NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer (PR Newswire)
Date: Wed, 7 May 2008 20:55:00 Etc/GMT
Tags:
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced the appointment of David B. Holtz as Vice President and Chief Financial Officer, effective May 8, 2008.